CIK 0000876343 · Non-accelerated filer<br>Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 943127919
- Phone
- 5105213390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-01 | Amin Dipti Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-07-01 | Russell Angus C. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-07-01 | KINGSLEY ALFRED D Director | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2021-07-01 | Mulroy Michael H. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-07-01 | Jayasuriya Anula Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-07-01 | BRADSHER NEAL C Director | Grant or award · OPTION TO PURCHASE COMMON SHARES | +50,000 | 50,000 | ||
| 2021-06-29 | ANDREWS DEBORAH J Director | Option exercise | +24,720 | $2.20 | $54K | 34,720 |
| 2021-06-29 | ANDREWS DEBORAH J Director | Sale | −19,142 | $2.93 | $56K | 15,578 |
| 2021-06-29 | ANDREWS DEBORAH J Director | Option exercise · Stock Option (right to buy) | −24,720 | 0 | ||
| 2021-06-29 | Russell Angus C. Director | Option exercise | +24,720 | $2.20 | $54K | 92,220 |
| 2021-06-29 | Russell Angus C. Director | Sale | −4,720 | $2.97 | $14K | 87,500 |
| 2021-06-29 | Russell Angus C. Director | Option exercise · Stock Option (right to buy) | −24,720 | 0 | ||
| 2021-06-21 | Cook Kevin Leon Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 |
Page 8 of 8 · 153 trades